Episode #65: Exploring Ivermectin's Potential in Cancer Treatment and Beyond

About the Guest(s): Dr. Kristin Hieshetter is the host of the "Functional Health Radio" podcast. Dr. Kristen is an expert in holistic health practices and functional medicine, bringing years of experience in treating patients with a focus on integrative approaches. Her keen interest lies in enabling individuals to reach optimal health through informed decisions and lifestyle changes. Dr. Kristen is known for her engaging discussions on contemporary health topics, as well as her dedication to improving public health awareness internationally.

Episode Summary: In this episode of "Functional Health Radio," Dr. Kristin Hieshetter delves into the intriguing topic of Ivermectin, exploring its potential use beyond its historical application as an anti-parasitic medication. Spurred by questions from her patients, Dr. Kristen investigates whether Ivermectin could be effectively repurposed for cancer treatment, a subject gaining them significant attention and research interest in recent years. She discusses how Ivermectin has a history of effectiveness in treating parasitic infections, but also reveals new and promising research that suggests its potential role in oncology.

The episode highlights Dr. Kristen's detailed exploration of scientific studies on Ivermectin's effect on various cancer types, including bladder cancer, esophageal cancer, pancreatic cancer, and triple-negative breast cancer. Dr. Kristen refers to multiple research articles and findings, emphasizing Ivermectin's mechanism of action, which includes inducing oxidative stress and DNA damage in cancer cells. Throughout the discussion, she provides a compelling narrative about the potential paradigm shifts in cancer treatment and urges listeners to consider these findings, especially if they or their loved ones are affected by these conditions.

Key Takeaways: Ivermectin, originally discovered as an anti-parasitic drug, is being researched for its potential use in cancer treatment, thanks to its ability to induce cancer cell death. Recent studies have shown that Ivermectin may enhance the efficacy of existing chemotherapy treatments, particularly for difficult-to-treat cancers like pancreatic and triple-negative breast cancer. Ivermectin has demonstrated the ability to selectively target and cause apoptosis in cancer cells without harming normal cells. While historical usage of Ivermectin in human treatments is well-established, ongoing research into its applications in oncology could mark a signif